IBT
International Biotechnology Trust’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $11.8M | Sell |
426,500
-97,000
| -19% | -$2.67M | 3.96% | 6 |
|
|
2023
Q2 | $15.7M | Buy |
523,500
+100,000
| +24% | +$3.01M | 4.79% | 5 |
|
|
2023
Q1 | $15.3M | Buy |
423,500
+40,000
| +10% | +$1.45M | 4.28% | 6 |
|
|
2022
Q4 | $13.7M | Buy |
383,500
+86,000
| +29% | +$3.07M | 4.22% | 7 |
|
|
2022
Q3 | $10.1M | Buy |
297,500
+288,896
| +3,358% | +$9.78M | 3.23% | 10 |
|
|
2022
Q2 | $298K | Sell |
8,604
-288,896
| -97% | -$9.99M | 3.1% | 10 |
|
|
2022
Q1 | $17.5M | Hold |
297,500
| – | – | 3.94% | 9 |
|
|
2021
Q4 | $8.68M | Hold |
297,500
| – | – | 1.93% | 20 |
|
|
2021
Q3 | $7.93M | Buy |
297,500
+95,064
| +47% | +$2.54M | 1.91% | 18 |
|
|
2021
Q2 | $6.23M | Buy |
+202,436
| New | +$6.23M | 1.65% | 20 |
|
|
2020
Q1 | – | Sell |
-19,953
| Closed | -$473K | – | 64 |
|
|
2019
Q4 | $473K | Hold |
19,953
| – | – | 0.17% | 57 |
|
|
2019
Q3 | $548K | Hold |
19,953
| – | – | 0.25% | 51 |
|
|
2019
Q2 | $659K | Sell |
19,953
-70,000
| -78% | -$2.31M | 0.24% | 60 |
|
|
2019
Q1 | $3.15M | Buy |
89,953
+69,000
| +329% | +$2.42M | 1.16% | 30 |
|
|
2018
Q4 | $547K | Hold |
20,953
| – | – | 0.34% | 40 |
|
|
2018
Q3 | $809K | Hold |
20,953
| – | – | 0.38% | 44 |
|
|
2018
Q2 | $1.25M | Hold |
20,953
| – | – | 0.48% | 42 |
|
|
2018
Q1 | $959K | Hold |
20,953
| – | – | 0.37% | 54 |
|
|
2017
Q4 | $834K | Hold |
20,953
| – | – | 0.29% | 58 |
|
|
2017
Q3 | $838K | Hold |
20,953
| – | – | 0.33% | 50 |
|
|
2017
Q2 | $902K | Sell |
20,953
-179,047
| -90% | -$7.71M | 0.34% | 53 |
|
|
2017
Q1 | $6.25M | Buy |
+200,000
| New | +$6.25M | 2.39% | 13 |
|